Timothy L. Jones Respire Rx Pharmaceuticals Inc. (RSPI) insider trading activity

RSPI Quotes by TradingView

Timothy L. Jones is CEO and President of RespireRx Pharmaceuticals Inc.. Currently has a direct ownership of 4.41 Million shares of RSPI, which is worth approximately $0. The most recent transaction as insider was on Sep 30, 2020, when has been sold 4,409,063 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 4.41M
0% 3M change
0% 12M change
Total Value Held $0

Timothy L. Jones Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 30 2020
BUY
Conversion of derivative security
-
4,409,063 Added 50.0%
4,409,063 Common Stock
TLJ

Timothy L. Jones

CEO and President
Glen Rock, NJ

Track Institutional and Insider Activities on RSPI

Follow RespireRx Pharmaceuticals Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RSPI shares.

Notify only if

Insider Trading

Get notified when an Respire Rx Pharmaceuticals Inc. insider buys or sells RSPI shares.

Notify only if

News

Receive news related to RespireRx Pharmaceuticals Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on RSPI